Data mining and safety analysis of FGFR tyrosine kinase inhibitors based on the FAERS database
Abstract Fibroblast growth factor receptor tyrosine kinase inhibitors (FGFR-TKIs), including erdafitinib, pemigatinib, and futibatinib, are a promising class of therapies for FGFR-driven cancers. While their efficacy is established in clinical trials, real-world safety data remain limited. This stud...
Saved in:
| Main Authors: | Ping Li, Liming Wu, Zhihui Song |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-11411-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world assessment of thromboembolic risk associated with tamoxifen
by: Jiajia Jia, et al.
Published: (2025-07-01) -
A pharmacovigilance study of vortioxetine based on data from the FDA adverse event reporting system
by: Miao Liu, et al.
Published: (2025-08-01) -
Safety assessment of temozolomidee: real-world adverse event analysis from the FAERS database
by: Yu Liu, et al.
Published: (2025-08-01) -
Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
by: Yuan-Yuan Wu, et al.
Published: (2025-05-01) -
A real-world pharmacovigilance study of Certolizumab pegol based on FAERS database
by: Meng Liu, et al.
Published: (2025-08-01)